Opponents of med-mal reform settle on new argument

NewsGuard 100/100 Score
The Hill: Tort Reform Opponents Knock 'Defensive Medicine' Argument
Trial lawyers and consumer advocates are trotting out a novel argument as they fight off tort reform proposals: they say medical malpractice suits, rather than driving over-use of costly tests by risk-averse doctors, instead prevent rationing. The political stars are aligning in favor of tort reform this Congress, with House Republicans vowing to pass a $250,000 cap on non-economic damages, and the White House setting aside $250 million in the 2012 budget for state experiments. One culprit, in lawyers' view, is the concept of "defensive medicine" that has been uniting Republicans who want to cut doctors' malpractice insurance bills and Democrats worried about wasteful medical spending that's bankrupting federal programs (Pecquet, 2/22).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine